Management of Hormone Refractory Prostate Cancer

Jean George Maxwell;

Abstract


Prostate cancer is the second most common malignancy in males and the leading cause of cancer death. Prostate cancer is initially androgen dependent and relies upon the androgen receptor (AR) to mediate the effects of androgens. The AR is also the target


Other data

Title Management of Hormone Refractory Prostate Cancer
Other Titles علاج سرطان البروستاتا المقاوم للهرمون
Authors Jean George Maxwell
Keywords Management of Hormone Refractory Prostate Cancer
Issue Date 2012
Description 
Prostate cancer is the second most common malignancy in males and the leading cause of cancer death. Prostate cancer is initially androgen dependent and relies upon the androgen receptor (AR) to mediate the effects of androgens. The AR is also the target

Attached Files

File SizeFormat
112814p6906.pdf19.1 MBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.